Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation
Edaravone (EDR) is a well-recognized lipophilic free radical scavenger for diseases including neurodegenerative disease, cardiovascular disease, and cancer. However, its oral use is restricted due to poor oral bioavailability (BA). The aim of present research was to enable its oral use by developing...
Main Authors: | Ankit Parikh, Krishna Kathawala, Chun Chuan Tan, Sanjay Garg, Xin-Fu Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2017.1337825 |
Similar Items
-
Self-nanomicellizing solid dispersion of edaravone: part I – oral bioavailability improvement
by: Parikh A, et al.
Published: (2018-07-01) -
Recent Advances in Lipid-Based Nanosystems for Gemcitabine and Gemcitabine–Combination Therapy
by: Saffiya Habib, et al.
Published: (2021-02-01) -
Evaluation of edaravone against radiation-induced oral mucositis in mice
by: Noriko Nakajima, et al.
Published: (2015-03-01) -
Efeitos neuroprotetores do Edaravone na hidrocefalia experimental induzida em ratos Wistar
by: Camila Araújo Bernardino Garcia
Published: (2015) -
Efeitos neuroprotetores do Edaravone na hidrocefalia experimental induzida em ratos Wistar
by: Garcia, Camila Araújo Bernardino
Published: (2015)